Clinical trial

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

NCT07747805

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-28

PhasePHASE2

Study timeline

Study start (estimated)2026-08-28Date precision: day

Registry last updated2026-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Obesity & Overweightunresolved

Sarcopeniaunresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

Sponsors & collaborators

The Cleveland Cliniclead sponsor

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07747805 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.